シリンジ・ニードルの世界市場：2024年～2031年

レポート概要

世界のシリンジ・ニードルの市場は、2023年の82億7,000万米ドルから2031年には135億9,000万米ドルに達し、2024-2031年の予測期間中にCAGRで6.4%の成長が予測されています。

シリンジは、薬剤の投与や体液の採取に使用される重要な医療機器です。シリンジは、体液を注入したり抽出したりするために特別に設計されており、さまざまな医療環境で不可欠なツールとなっています。

ニードルは、薬剤の投与や採血に不可欠な鋭く尖った器具で、通常、シリンジと一緒に使用されます。様々な医療処置に欠かせないもので、いくつかの種類があり、それぞれデザインと使用目的に基づいて特定の用途に設計されています。

シリンジもニードルも、薬やワクチン、採血を安全かつ効果的に行うための、現代医療の基本的な要素です。患者の快適性を高め、安全性を向上させ、感染や傷害のリスクを最小限に抑えるために、その設計と機能性は絶えず進歩しています。

市場力学：

促進要因

慢性疾患の有病率の増加と技術の進歩

世界のシリンジ・ニードル市場の需要を促進する要因は複数あります。主な要因の1つは、慢性疾患の有病率の増加と技術の進歩です。慢性疾患の有病率の増加は、シリンジ・ニードルの世界の需要拡大の主な要因です。糖尿病、がん、心血管疾患などの慢性疾患は、多くの場合注射による定期的な薬剤投与を必要とするため、シリンジの必要性が高まっています。

定期的な注射を必要とする患者の増加に伴い、メーカーはこのニーズの高まりに対応するため、革新的な製品やソリューションで対応しています。これらの疾患を持つ患者は、投薬管理のために定期的な注射を必要とすることが多いため、使いやすく効率的な器具のニーズが高まっています。シリンジ・ニードルの設計における技術革新は、患者の快適性と安全性を大幅に向上させ、臨床現場におけるこれらの機器の受け入れと使用の増加に繋がっています。これらの進歩には、安全針や注射時の痛みを最小限に抑える技術の開発が含まれます。

さらに、業界の主要企業は革新的な製品を発表し、この市場の成長を促進する技術的進歩を遂げています。例えば、テルモ・インディアは2023年11月、糖尿病管理のために毎日インスリン注射を必要とする患者向けに特別に設計された新しいインスリンシリンジを発表しました。この製品はテルモ・メディカル・ケア・ソリューションズのライフケア・ソリューションズ部門の製品で、インスリン投与時の患者の快適性と使いやすさを高めることを目的としています。

同様に、テルモ・インディアは2022年9月、定期的なインスリン注射やその他のセルフメディケーションが必要な患者向けに設計された滅菌ペン型ニードル「FineGlide」の発売を発表しました。この新しいニードルは、インドで最も一般的に使用されているペン型シリンジと互換性があり、患者の快適性を高め、投薬計画の遵守を促進します。

抑制要因

製品リコール、厳しい規制政策と規制、針刺しによる怪我や感染リスク、代替ドラッグデリバリー技術の採用などの要因が市場の妨げになると予想されます。

市場セグメンテーション

世界のシリンジ・ニードル市場は、製品タイプ、ユーザビリティ別、容量、年齢層、用途、エンドユーザー、地域によって区分されます。

採血用シリンジ・ニードル部門は世界のシリンジ・ニードル市場シェアの約51.8％を占める

採血用シリンジ・ニードルセグメントは、予測期間中最大の市場シェアを占めると予想されます。このセグメントは、診断検査と患者モニタリングのニーズの高まりによって牽引されています。この市場が進化を続ける中、設計と技術の革新は安全性と効率を高め、最終的に患者の転帰と医療提供を改善する上で極めて重要な役割を果たします。

採血用シリンジ・ニードルは、患者から安全かつ効率的に血液を採取するために特別に設計された重要な医療機器です。その設計と機能性は、病院、血液銀行、診断研究所を含む様々な医療環境において非常に重要です。

さらに、業界の主なプレーヤーは、革新的なシリンジ・ニードルの開発や、このセグメントの市場成長を促進する製品承認により注力しています。例えば、2024年4月、患者の痛みや不快感を軽減し、1回の穿刺で採血を成功させるため、BDはインドでBD Vacutainer UltraTouch Push Button Blood Collection Setを発売しました。この革新的なセットには、より細い針を使用できるBDライトゲージテクノロジーが組み込まれており、BDペンタポイントテクノロジーと組み合わせることで、患者の挿入時の痛みを大幅に軽減します。さらに、BD Vacutainer UltraTouchは、針を傷つけるリスクを88％低減するBDプッシュボタンテクノロジーを搭載しています。

同様に2023年11月、BDは米国食品医薬品局（FDA）から510（k）認可を受けたPIVO Pro Needle-free Blood Collection Deviceを発表しました。この新しいデバイスは一体型カテーテルとの互換性を持つように設計されており、BDのビジョンである「One-Stick Hospital Stay」をさらに可能にしています。

市場の地域別シェア

北米はシリンジ・ニードルの世界市場シェアの約43.6%を占める

北米地域は、糖尿病、心血管疾患、がんなどの慢性疾患の罹患率の増加が北米のシリンジ・ニードル市場の重要な促進要因となっているため、予測期間中に最大の市場シェアを占めると予想されます。慢性疾患を患う患者は、投薬管理のために定期的な注射を頻繁に受ける必要があります。糖尿病患者は毎日数回インスリンを投与しなければならず、これがシリンジの需要を直接押し上げています。

さらに、注射薬に対する需要の増加、技術の進歩、在宅ヘルスケアの導入拡大、規制当局の支援と個人の意識の高まり、製品の承認などが、この地域の市場成長を後押ししています。

加えて、この地域には多くの主要プレーヤーが存在し、医療インフラが整備され、主要プレーヤーの製品上市や承認が市場成長の原動力となっています。例えば、2024年3月、米国食品医薬品局（FDA）が特定のプラスチック製シリンジ、特に中国製シリンジの評価を継続中であることから、BD（ベクトン・ディッキンソン・アンド・カンパニー）はネブラスカ州とコネチカット州にある施設でシリンジの国内生産を増やすと発表しました。

同様に、2024年3月、米国食品医薬品局（FDA）は中国製のプラスチック製シリンジおよび安全針に関する安全性に関して、HTL-Strefa Inc.HTL-Strefa社のFDA認証済み欧州製受動的安全針DropSafe Sicuraは、安全性、信頼性、性能の最高水準を示し、最適な患者ケアと安全性の実践を保証します。

また、2023年2月、非公開会社である医療機器メーカー、ゼファルス・イノベーションズは、エアロジェクト3ml安全シリンジについて、米国食品医薬品局（FDA）から初の510（k）販売承認を取得したと発表しました。この承認は同社にとって重要なマイルストーンであり、医療従事者と患者の安全性を高めるよう設計されたエアロジェクトシリンジの販売が可能になりました。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 慢性疾患の増加と技術の進歩
  • 抑制要因
    • 製品回収
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 採血用シリンジ・ニードル
• 眼科用シリンジ・ニードル
• 骨髄用シリンジ・ニードル
• カテーテル用シリンジ・ニードル
• 歯科用シリンジ・ニードル
• 脊椎麻酔用シリンジ・ニードル
• 縫合用シリンジ・ニードル
• その他

第7章 ユーザビリティ別

• 使い捨て
• 再使用可能

第8章 容量別

• 1mL シリンジ
• 2～3mL シリンジ
• 5mL シリンジ
• 10mL シリンジ

第9章 年齢層別

• 小児
• 成人
• 高齢者

第10章 用途別

• 一般外科
• 呼吸器
• 整形外科
• 心臓血管
• 歯科
• 神経科
• 眼科
• 泌尿器科
• その他

第11章 エンドユーザー別

• 病院・専門クリニック
• 診断センター
• 在宅医療
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第13章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第14章 企業プロファイル

• BD
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• B. Braun SE
• Cardinal Health
• Terumo Medical Corporation
• Gerresheimer AG
• Nipro Corporation
• SCHOTT Pharma AG & Co. KGaA
• Hindustan Syringes & Medical Devices Ltd
• ICU Medical, Inc.
• Catalent, Inc

第15章 付録

Report Overview

The Global Syringes and Needles Market reached US$ 8.27 billion in 2023 and is expected to reach US$ 13.59 billion by 2031 growing with a CAGR of 6.4% during the forecast period 2024-2031.

Syringes are essential medical devices used for administering medications and collecting bodily fluids. They are specifically designed to either inject fluids into the body or extract them, making them vital tools in a variety of healthcare environments.

Needles are sharp, pointed instruments essential for delivering medications or drawing blood, typically used alongside syringes. They are crucial in various medical procedures and come in several types, each designed for specific applications based on their design and intended use.

Both syringes and needles are fundamental components of modern healthcare, facilitating the safe and effective delivery of medications, vaccines, and blood collection. Their design and functionality are continuously advancing to enhance patient comfort, improve safety, and minimize the risk of infections and injuries.

Market Dynamics: Drivers

Increasing prevalence of chronic diseases and technological advancements

Multiple factors drive the demand for the global syringes and needles market. One of the primary factors is the increasing prevalence of chronic diseases and technological advancements. The increasing prevalence of chronic diseases is a major driver for the growing demand for syringes and needles globally. Chronic conditions such as diabetes, cancer, and cardiovascular diseases require regular medication administration, often through injections, which is fueling the need for injection devices.

As the number of patients requiring regular injections increases, manufacturers are responding with innovative products and solutions to meet this rising need. Patients with these conditions often require regular injections for medication management, which leads to a growing need for user-friendly and efficient devices. Innovations in syringe and needle design are significantly enhancing patient comfort and safety, leading to increased acceptance and usage of these devices in clinical settings. These advancements include the development of safety needles and technologies that minimize pain during injections.

Moreover, key players in the industry have innovative product launches and technological advancements that would drive this market growth. For instance, in November 2023, Terumo India introduced a new Insulin Syringe specifically designed for patients who require daily insulin injections to manage diabetes. This product is part of the Life Care Solutions division of Terumo Medical Care Solutions and aims to enhance patient comfort and ease of use during insulin administration.

Similarly, in September 2022, Terumo India announced the launch of FineGlide, a sterile pen needle designed for patients who require regular insulin injections or other forms of self-medication. This new needle is compatible with the most commonly used pen devices available in India, enhancing patient comfort and promoting better adherence to medication regimens.

Restraints

Factors such as product recalls, stringent regulatory policies and regulations, injuries and infection risks associated with the needlestick, and adoption of alternative drug delivery technologies, are expected to hamper the market.

Market Segment Analysis

The global syringes and needles market is segmented based on product type, usability, capacity, age group, application, end-user, and region.

The blood collection syringes & needle segment accounted for approximately 51.8% of the global syringes and needles market share

The blood collection syringes & needles segment is expected to hold the largest market share over the forecast period. This segment is driven by the growing need for diagnostic testing and patient monitoring. As this market continues to evolve, innovations in design and technology will play a pivotal role in enhancing safety and efficiency, ultimately improving patient outcomes and healthcare delivery.

Blood collection syringes and needles are essential medical devices specifically engineered to facilitate the safe and efficient withdrawal of blood from patients. Their design and functionality are critical in various healthcare settings, including hospitals, blood banks, and diagnostic laboratories.

Moreover, key players in the industry more focus on developing innovative syringes & needles and product approvals that would propel this segment's growth in the market. For instance, in April 2024, to reduce patient pain and discomfort while ensuring successful blood collection with a single prick, BD launched the BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This innovative set incorporates BD RightGauge technology, which allows for the use of a thinner needle and is combined with BD PentaPoint Technology, significantly decreasing insertion pain for patients. Additionally, the BD Vacutainer UltraTouch features BD Push Button Technology, which lowers the risk of needle injuries by 88%.

Similarly, in November 2023, BD introduced the PIVO Pro Needle-free Blood Collection Device, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new device is designed to be compatible with integrated catheters, further enabling BD's "One-Stick Hospital Stay" vision.

Market Geographical Share

North America accounted for approximately 43.6% of the global syringes and needles market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is a significant driver of the syringes and needles market in North America. Patients suffering from chronic diseases frequently need to receive regular injections to manage their medications. People with diabetes must administer insulin several times each day, which directly boosts the demand for syringes.

Moreover, growing demand for injectable drugs, technological advancements, increased adoption of home healthcare, regulatory support & growing awareness among individuals, and product approvals, are driving the market growth in the region.

In addition, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, key player's product launches, and approvals would drive this market growth. For instance, in March 2024, the U.S. Food and Drug Administration's (FDA) ongoing evaluation of certain plastic syringes, particularly those manufactured in China, BD (Becton, Dickinson, and Company) has announced that it is increasing domestic production of syringes in its facilities located in Nebraska and Connecticut.

Similarly, in March 2024, the U.S. Food and Drug Administration (FDA) concerning the safety of plastic syringes and safety needles produced in China, HTL-Strefa Inc. is pleased to provide healthcare providers, facilities, and consumers with a reliable and safe alternative. Their FDA-cleared, European-manufactured passive safety needle, DropSafe Sicura, exemplifies the highest standards of safety, reliability, and performance, ensuring alignment with optimal patient care and safety practices.

Also, in February 2023, Zephyrus Innovations, a privately-owned medical device company, announced that it had received its first 510(k) Marketing Approval from the U.S. Food and Drug Administration (FDA) for its Aeroject 3ml safety syringe. This approval marks a significant milestone for the company, allowing it to market the Aeroject syringe, which is designed to enhance safety for healthcare professionals and patients alike.

Market Segmentation

By Product Type

Blood Collection Syringes & Needles

Ophthalmic Syringes & Needles

Bone Mas these arrow Syringes & Needles

Catheter Syringes & Needles

Dental Syringes & Needles

Spinal Anesthesia Syringes & Needles

Suture Syringes & Needles

Others

By Usability

Disposable

Reusable

By Capacity

1 mL Syringe

2- 3 mL Syringe

5 mL Syringe

10 mL Syringe

By Age Group

Pediatrics

Adults

Geriatric

By Application

General Surgery

Respiratory

Orthopedics

Cardiovascular

Dental

Neurology

Ophthalmology

Urology

Others

By End User

Hospital & Specialty Clinics

Diagnostic Centers

Homecare Settings

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the syringes and needles market include BD, B. Braun SE, Cardinal Health, Terumo Medical Corporation, Gerresheimer AG, Nipro Corporation, SCHOTT Pharma AG & Co. KGaA, Hindustan Syringes & Medical Devices Ltd, ICU Medical, Inc., and Catalent, Inc among others.

Key Developments

In March 2024, Hindustan Syringes and Medical Devices (HMD), a major manufacturer of disposable and auto-disable syringes in India, launched Dispojekt - an indigenous single-use safety syringe designed to reduce the incidence of needle stick injuries (NSIs) among healthcare workers. A needle stick injury (NSI) occurs when a hollow-bore needle accidentally penetrates the skin and potentially exposes the healthcare worker to another person's blood or body fluid. These injuries pose a serious risk of transmission of bloodborne pathogens such as hepatitis B, hepatitis C, and HIV.

In October 2022, Terumo Pharmaceutical Solutions (TPS), launched the PLAJEX 2.25 mL with Tapered Needle, a ready-to-fill polymer syringe specifically designed for the biotech market. This innovative syringe addresses the unique challenges associated with delivering complex biotech drugs, particularly those with larger volumes and high viscosity, such as concentrated monoclonal antibodies.

Why Purchase the Report?

To visualize the global syringes and needles market segmentation based on product type, usability, capacity, age group, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the syringes and needles market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global syringes and needles market report would provide approximately 86 tables, 94 figures, and 184 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Usability
• 3.3. Snippet by Capacity
• 3.4. Snippet by Age Group
• 3.5. Snippet by Application
• 3.6. Snippet by End-User
• 3.7. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Chronic Diseases and Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. Product Recalls
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Blood Collection Syringes & Needles*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Ophthalmic Syringes & Needles
• 6.4. Bone Marrow Syringes & Needles
• 6.5. Catheter Syringes & Needles
• 6.6. Dental Syringes & Needles
• 6.7. Spinal Anesthesia Syringes & Needles
• 6.8. Suture Syringes & Needles
• 6.9. Others

7. By Usability

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
  • 7.1.2. Market Attractiveness Index, By Usability
• 7.2. Disposable *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Reusable

8. By Capacity

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
  • 8.1.2. Market Attractiveness Index, By Capacity
• 8.2. 1 mL Syringe *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. 2- 3 mL Syringe
• 8.4. 5 mL Syringe
• 8.5. 10 mL Syringe

9. By Age Group

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 9.1.2. Market Attractiveness Index, By Age Group
• 9.2. Pediatrics *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Adults
• 9.4. Geriatric

10. By Application

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.1.2. Market Attractiveness Index, By Application
• 10.2. General Surgery *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Respiratory
• 10.4. Orthopedics
• 10.5. Cardiovascular
• 10.6. Dental
• 10.7. Neurology
• 10.8. Ophthalmology
• 10.9. Urology
• 10.10. Others

11. By End-User

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.1.2. Market Attractiveness Index, By End-User
• 11.2. Hospital & Specialty Clinics *
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 11.3. Diagnostic Centers
• 11.4. Homecare Settings
• 11.5. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
  • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
  • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.9.1. U.S.
    • 12.2.9.2. Canada
    • 12.2.9.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
  • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
  • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.9.1. Germany
    • 12.3.9.2. U.K.
    • 12.3.9.3. France
    • 12.3.9.4. Spain
    • 12.3.9.5. Italy
    • 12.3.9.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
  • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
  • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.9.1. Brazil
    • 12.4.9.2. Argentina
    • 12.4.9.3. Rest of South America
• 12.5. Asia-Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
  • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
  • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.9.1. China
    • 12.5.9.2. India
    • 12.5.9.3. Japan
    • 12.5.9.4. South Korea
    • 12.5.9.5. Rest of Asia-Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
  • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Capacity
  • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

• 13.1. Competitive Scenario
• 13.2. Market Positioning/Share Analysis
• 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

• 14.1. BD *
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Financial Overview
  • 14.1.4. Key Developments
• 14.2. B. Braun SE
• 14.3. Cardinal Health
• 14.4. Terumo Medical Corporation
• 14.5. Gerresheimer AG
• 14.6. Nipro Corporation
• 14.7. SCHOTT Pharma AG & Co. KGaA
• 14.8. Hindustan Syringes & Medical Devices Ltd
• 14.9. ICU Medical, Inc.
• 14.10. Catalent, Inc (*LIST NOT EXHAUSTIVE)

15. Appendix

• 15.1. About Us and Services
• 15.2. Contact Us